Disseminated Intravascular Coagulation Galila Zaher MRCPath 2005.
Disseminated Intravascular Dic Auto Saved]
Transcript of Disseminated Intravascular Dic Auto Saved]
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
1/35
Presented by
Chandika Dahal
Bsc.mlt 6th sem
Nobel college
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
2/35
CONTENTS
y Introduction
y Causes
y Pathophysiologyy Coagulation
y Signs and symptoms(clinical features)
y Conditions
y
Diagnosisy Treatment
y Summary
y References
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
3/35
INTRODUCTIONy Also known as disseminated intravascular coagulopathy or
consumptive coagulopathy.
y It is pathological activation of coagulation(blood clotting)mechanism that happens in response to a variety ofdiseases.
y It is a hemorrhagic disorder in which the diffuse
intravascular coagulation causes haemostatic defect.y DIC leads to the formation of small blood clots inside the
blood vessels throughout the body.
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
4/35
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
5/35
An acquired syndrome characterized by the intravascularactivation of coagulation with loss of localization arising
from different causes. It can originate from and causedamage to the microvasculature, which if sufficientlysevere, can produce organ dysfunction
Taylor, FB, et al. Thromb Haemost 2001;86:1327
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
6/35
DICy An acquired syndrome
characterized bysystemic intravascular
coagulationy Coagulation is always the
initial event.y Most morbidity and
mortality depends on
extent of intravascularthrombosisy Multiple causes
6
ThrombosisThrombosis
FibrinFibrin
Red Blood CellRed Blood Cell
PlateletPlatelet
WWW. Coumadin.com
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
7/35
DICy An acquired syndrome
characterized bysystemic
intravascularcoagulation
y Coagulation is always theinitial event
SYSTEMIC ACTIVATION
OF COAGULATION
Intravascular deposition
offibrin
Depletionofplateletsandcoagulation
factors
Thrombosisofsmalland
midsizevesselsBleeding
OrganfailureDEATHDEATH
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
8/35
CAUSES
y It may be acute ,subacute or chronic.
y Cancers of lungs,pancreas,prostate,and stomach as well as
acute myeloid leukemia(particularlyAPML).y Obstetric:abruptio placentae,pre-eclampsia,amniotic fluid
embolism.
y Massive tissue injury:Trauma,burns,extensive surgery.
y Infections: Gram negative sepsis,Neisseriameningitidis,streptococcuspneumoniae,malaria,histoplasmosis,asperillosis,Rockeymountain spotted fever.
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
9/35
y Miscellaneous: liver disease, snakes bites,shock,heatstroke,vasculitis,aortic aneurysm, serotonin syndrome.
yViral: Arena viruses causing Argentine hemorrhagic fever orBolivian hemorrhagic fever.
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
10/35
PATHOPHYSIOLOGY
DIC may caused by:
1. Release or entry of tissue factors that act as coagulant
into the blood stream.2. Extensive endothelial damage.
Released coagulants are normally inactivated bynaturally occurring circulating inhibitors and are clearedby RE system.
The occurrence of intravascular coagulation isaugmented by the stasis which prevents the circulatinginhibitors by reaching the coagulants and by REblockade.
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
11/35
Pathophysiology ofDICy Activation of Blood Coagulation
y Suppression of PhysiologicAnticoagulant Pathways
y Impaired Fibrinolysisy Cytokines
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
12/35
Pathophysiology ofDICy Activation of Blood Coagulation
y Tissue factor/factor VIIa mediated thrombin generation via
the extrinsic pathwayy complex activates factor IXand X
y TF
y endothelial cells
y monocytes
y Extravascular:
y lung
y kidney
y epithelial cells
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
13/35
Pathophysiology ofDICy Suppression of PhysiologicAnticoagulant Pathways
y reduced antithrombin III levels
y reduced activity of the protein C-protein S systemy Insufficient regulation of tissue factor activity by tissue factor
pathway inhibitor (TFPI)
y inhibits TF/FVIIa/Fxa complex activity
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
14/35
Pathophysiology ofDICy Impaired Fibrinolysis
y relatively suppressed at time of maximal activation of
coagulation due to increased plasminogen activatorinhibitor type 1
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
15/35
Coagulationy Intrinsic Pathwayy Extrinsic Pathwayy Common Pathwayy Contact Pathwayy
Tissue Factor Pathwayy Primary factor in DIC
5
Contact Tissue Factor + VIITissue Factor + VII
XIIIXIIIaa
XIIIXIII
ThrombinThrombin
FibrinFibrin(strong)(strong)
FibrinogenFibrinogen FibrinFibrin(weak)(weak)
IXIX
XIXI
XIXIaa
IXIXaa
XXaaVVaa
XIIXIIaa
ProthrombinProthrombin
TF-VIITF-VIIaa
(Prothrombinase)(Prothrombinase)
PLPL
PLPL
(Tenase)(Tenase)
VIIIVIIIaa
PLPL
XX
Intrinsic Pathway
HKHKaa
Extrinsic Pathway
Common Pathway
TF Pathway
Coagulation PathwaysCoagulation Pathways
Protein C, ProteinS, Antithrombin III
Www.coumadin.com
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
16/35
Anticlotting Mechanismsy Antithrombin III (ATIII):
y The major inhibitor of thecoagulation cascade.
y Inhibits Thrombiny Inhibits activated Factors IX, X,
XI, and XII.
y Activity is enhanced by heparin.
y Tissue factor pathway inhibitorTFPI
5
Contact Tissue Factor + VIITissue Factor + VII
XIIIXIIIaa
XIIIXIII
ThrombinThrombin
FibrinFibrin(strong)(strong)
FibrinogenFibrinogen FibrinFibrin(weak)(weak)
IXIX
XIXI
XIXIaa
IXIXaa
XXaaVVaa
XIIXIIaa
ProthrombinProthrombin
TF-VIITF-VIIaa
(Prothrombinase)(Prothrombinase)
PLPL
PLPL
(Tenase)(Tenase)
VIIIVIIIaa
PLPL
XX
Intrinsic Pathway
HKHKaa
Extrinsic Pathway
Common Pathway
TF Pathway
Coagulation PathwaysCoagulation Pathways
Protein C, Protein
S, Antithrombin III
Www.coumadin.com
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
17/35
Anticlotting Mechanismsy Protein C
y Activated byThrombin/Thrombomodulin
y Anticoagulant and fibrinolyticactivity.
y Vitamin K and Protein S arecofactors
y Protein S
5
Contact Tissue Factor + VIITissue Factor + VII
XIIIXIIIaa
XIIIXIII
ThrombinThrombin
FibrinFibrin(strong)(strong)
FibrinogenFibrinogen FibrinFibrin(weak)(weak)
IXIX
XIXI
XIXIaa
IXIXaa
XXaaVVaa
XIIXIIaa
ProthrombinProthrombin
TF-VIITF-VIIaa
(Prothrombinase)(Prothrombinase)
PLPL
PLPL
(Tenase)(Tenase)
VIIIVIIIaa
PLPL
XX
Intrinsic Pathway
HKHKaa
Extrinsic Pathway
Common Pathway
TF Pathway
Coagulation PathwaysCoagulation Pathways
Protein C, ProteinS, Antithrombin III
Www.coumadin.com
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
18/35
Fibrinolytic Systemy Plasmin
y Produced fromPlasminogen by Tissue
Plasminogen activator(TPA)
y Degrades Fibrin andFibrinogen (Fibrindegradation products,
FDP)y Degrades Factors V, VIII,IX, XI, and XII.
y Activity is inhibited byAntiplasmin.
7
FibrinolysisFibrinolysisPlasminogen
Plasmin
Fibrin, fibrinogenFibrin, fibrinogen
ActivationActivation
Extrinsic: t-PA,Extrinsic: t-PA, urokinaseurokinase
Intrinsic: factor XIIa, HMWK,Intrinsic: factor XIIa, HMWK, kallikreinkallikrein
Exogenous:Exogenous: streptokinasestreptokinase
Fibrin, fibrinogenFibrin, fibrinogen
degradation productsdegradation products
Www.coumadin.com
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
19/35
Fibrinolytic Inhibitorsy Antiplasmin
y Inactivates plasmin rapidly.
y Acts slowly on plasminsequestered in the fibrin
clot.
y Inactivates factors XI and XIIslowly.
y Plasminogen -ActivatorI
nhibitor-1(PAI
-1)y Inhibits the function of TPAy Also has some inhibitory
activity against urokinase,plasmin, thrombin, activatedProtein C, factors and XII, and
kallikrein
7
FibrinolysisF
ibrinolysisPlasminogen
Plasmin
Fibrin, fibrinogenFibrin, fibrinogen
ActivationActivation
Extrinsic: t-PA,Extrinsic: t-PA, urokinaseurokinase
Intrinsic: factor XIIa, HMWK,Intrinsic: factor XIIa, HMWK, kallikreinkallikrein
Exogenous:Exogenous: streptokinasestreptokinase
Fibrin, fibrinogenFibrin, fibrinogendegradation productsdegradation products
Www.coumadin.com
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
20/35
CLINICALFEATURES
Two main clinical features of DIC
1.Bleeding
2.Organ damage
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
21/35
Clinical Manifestations ofDICORGAN ISCHEMIC HEMOR.
Skin Pur. FulminansGangrene
Acral cyanosis
Petechiae
Echymosis
OozingCNS Delirium/Coma
Infarcts
Intracranial
bleeding
Renal Oliguria/AzotemiaCortical Necrosis
Hematuria
Cardiovascular MyocardialDysfxn
Pulmonary Dyspnea/HypoxiaInfarct
Hemorrhagiclung
GI
Endocrine
Ulcers, Infarcts
Adrenal infarcts
Massive
hemorrhage.
Ischemic Findingsareearliest!
Bleedingisthemos obviousclinicalfinding
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
22/35
Clinical Manifestations ofDIC
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
23/35
Conditions Associated With DICy Malignancy
y Leukemia
y Metastatic diseasey Cardiovascular
y Post cardiac arrest
y Acute MI
y Prosthetic devicesy Hypothermia/Hyperthermi
a
y Pulmonary
y ARDS/RDS
y Pulmonary embolismy Severe acidosis
y Severe anoxia
y Collagen vascular disease
y Anaphylaxis
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
24/35
Conditions Associated With DICy Infectious/Septicemia
y Bacterialy
Gm - / Gm +y Viral
y CMV
y Varicella
y Hepatitis
y Fungal
y Intravascular hemolysis
y Acute Liver Disease
y Tissue Injuryy trauma
y
extensive surgeryy tissue necrosis
y head trauma
y Obstetricy Amniotic fluid emboli
y Placental abruption
y Eclampsia
y Missed abortion
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
25/35
Microscopic findings in DIC
y Fragments
y Schistocytesy Paucity of platelets
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
26/35
Laboratory diagnosisy Thrombocytopeniay plat count
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
27/35
Differential Diagnosisy Severe liver failure
yVitamin K deficiency
y Liver diseasey Thrombotic thrombocytopenic purpura
y Congenital abnormalities of fibrinogen
y HELLP syndrome
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
28/35
Laboratory Tests Used in DICy D-dimer*
y Antithrombin III*
y F. 1+2*y FibrinopeptideA*
y Platelet factor 4*
y Fibrin Degradation Prod
y Platelet count
y Protamine test
y Thrombin time
y Fibrinogen
y Prothrombin timey Activated PTT
y Protamine test
y Reptilase time
y Coagulation factor levels
*Most reliable test
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
29/35
Treatment ofDICy Stopthetriggeringprocess .
y The only proven treatment!
y Supportive therapyy No specific treatments
y Plasma and platelet substitution therapy
y Anticoagulants
y Physiologic coagulation inhibitors
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
30/35
Plasma therapyy Indications
y Active bleeding
y Patient requiring invasive procedures
y Patient at high risk for bleeding complications
y Prophylactic therapy has no proven benefit.
y Cons:
y Fresh frozen plasma(FFP):y provides clotting factors, fibrinogen, inhibitors, and platelets in
balanced amounts.y Usual dose is 10-15 ml/kg
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
31/35
Platelet therapyy Indications
y Active bleeding
y Patient requiring invasive proceduresy Patient at high risk for bleeding complications
y Platelets
y approximate dose 1 unit/10kg
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
32/35
Bloody Replaced as needed to maintain adequate oxygen delivery.
y Blood loss due to bleeding
y
RBC destruction (hemolysis)
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
33/35
Summaryy DIC is a syndrome characterized systemic intravascular
coagulation.
y
Coagulation is the initial event and the extent of intravascularthrombosis has the greatest impact on morbidity and mortality.
y Important link between inflammation and coagulation.
y Morbidity and mortality remain high.
y The only proven treatment is reversal or control of the
underlying cause.
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
34/35
REFERENCES
y De Gruchys Clinical haematology in medical practice 5th
edu.
y
www.coumdin.com.y Teachers note.
-
8/3/2019 Disseminated Intravascular Dic Auto Saved]
35/35
y
THA
NK YOU